Tracking binding modes of 1,2,4-trisubstituted imidazolinone P38 MAP kinase and ERK-2 inhibitors

被引:2
|
作者
Rao, Shashidhar N. [1 ]
机构
[1] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
关键词
p38 MAP Kinase; ERK-2; Docking score; DFG-out; Hydrogen bonding; Spearman-R correlation; pi-Cation interactions; ACTIVATED PROTEIN-KINASE; PANCREATIC-CANCER; DOCKING; IDENTIFICATION; DERIVATIVES; PATHWAYS; DESIGN; SMILES; ERK1/2; CELLS;
D O I
10.1016/j.jmgm.2017.07.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Putative binding modes of recently reported p38 MAP Kinase and ERK-2 inhibitors containing 1,2,4-trisubstituted imidazolinone have been investigated using molecular docking methods In the case of p38 MAP Kinase, X-ray structures with both DFG-in and DFG-out conformations of the activation loop have been employed for docking studies. The present investigations demonstrate that the DFG-out conformation of the activation loop in p38 MAP Kinase accommodates the 1,2,4-tri-substituted imidazolinones with greater computed binding affinities than the alternative DFG-in conformation. The best scoring binding modes in ERK-2 are distinctly different from those found in the p38 MAP Kinase structures. Both sets of binding modes are characterized by an extensive network of hydrophobic and pi-cation interactions, with the hinge region showing little hydrogen bonding propensity with the top-ranked poses. Thus, these docking studies provide a putative pathway for lead optimizations in which hydrogen bonding interactions with the hinge region residues are feasible. (c) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 50 条
  • [41] Synthesis of imidazo[2,1-a]phthalazines, potential inhibitors of p38 MAP kinase.: Prediction of binding affinities of protein Ligands
    Mavel, S
    Thery, I
    Gueiffier, A
    ARCHIV DER PHARMAZIE, 2002, 335 (01) : 7 - 14
  • [42] Monocyte colony stimulating factor induction by cyclic strain involves differential ERK1/2 and p38 MAP kinase regulation
    Guest, TM
    Taylor, WR
    HYPERTENSION, 1998, 32 (03) : 591 - 591
  • [43] The role of ERK 1/2 and p38 MAP-kinase pathways in Taxol-induced apoptosis in human ovarian carcinoma cells
    Seidman, R
    Gitelman, I
    Sagi, O
    Horwitz, SB
    Wolfson, M
    EXPERIMENTAL CELL RESEARCH, 2001, 268 (01) : 84 - 92
  • [44] Regulation of NFκB activation in anti-phospholipid syndrome:: Involvement of ERK1/2 and p38 MAP kinase pathways
    Buendía, P
    López-Pedrera, C
    Barbarroja, N
    Siendones, E
    Montiel-Duarte, C
    Dorado, G
    Aguirre, MA
    Cuadrado, MJ
    Torres, A
    Velasco, F
    PROCEEDINGS OF THE 18TH INTERNATIONAL CONGRESS ON THROMBOSIS, 2004, : 111 - 114
  • [45] Thermal denaturation:: A method to rank slow binding, high-affinity p38α MAP kinase inhibitors
    Kroe, RR
    Regan, J
    Proto, A
    Peet, GW
    Roy, T
    Landro, LD
    Fuschetto, NG
    Pargellis, CA
    Ingraham, RH
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4669 - 4675
  • [46] Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes
    Angell, Richard M.
    Angell, Tony D.
    Bamborough, Paul
    Bamford, Mark J.
    Chung, Chun-wa
    Cockerill, Stuart G.
    Flack, Stephen S.
    Jones, Katherine L.
    Laine, Dramane I.
    Longstaff, Timothy
    Ludbrook, Steve
    Pearson, Rosannah
    Smith, Kathryn J.
    Smee, Penny A.
    Somers, Don O.
    Walker, Ann L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4433 - 4437
  • [47] Short cut to 1,2,3-triazole-based p38 MAP kinase inhibitors via [3+2]-cycloaddition chemistry
    Diner, Peter
    Andersson, Terese
    Kjellen, Jimmy
    Elbing, Karin
    Hohmann, Stefan
    Grotli, Morten
    NEW JOURNAL OF CHEMISTRY, 2009, 33 (05) : 1010 - 1016
  • [48] Acute Lymphoid and Gastrointestinal Toxicity Induced by Selective p38α Map Kinase and Map Kinase-Activated Protein Kinase-2 (MK2) Inhibitors in the Dog
    Morris, Dale L.
    O'Neil, Shawn P.
    Devraj, Rajesh V.
    Portanova, Joseph P.
    Gilles, Richard W.
    Gross, Cindy J.
    Curtiss, Sandra W.
    Komocsar, Wendy J.
    Garner, Debra S.
    Happa, Fernando A.
    Kraus, Lori J.
    Nikula, Kristen J.
    Monahan, Joseph B.
    Selness, Shaun R.
    Galluppi, Gerald R.
    Shevlin, Kimberly M.
    Kramer, Jeffrey A.
    Walker, John K.
    Messing, Dean M.
    Anderson, David R.
    Mourey, Robert J.
    Whiteley, Laurence O.
    Daniels, John S.
    Yang, Jerry Z.
    Rowlands, Philip C.
    Alden, Carl L.
    Davis, John W., II
    Sagartz, John E.
    TOXICOLOGIC PATHOLOGY, 2010, 38 (04) : 606 - 618
  • [49] The activity of the MAP-kinases p38 and ERK1/2 are increased in lesional psoriatic skin
    Johansen, C
    Kragballe, K
    Westergaard, M
    Henningsen, J
    Kristiansen, K
    Iversen, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
  • [50] ERK and p38 MAP kinase are involved in arachidonic acid release induced by H2O2 and PDGF in mesangial cells
    Hayama, M
    Inoue, R
    Akiba, S
    Sato, T
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 282 (03) : F485 - F491